MMP9 | Dog | abdominal aortic aneurysm | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:21256058|REF_RGD_ID:13207313 |
MMP9 | Dog | abdominal aortic aneurysm | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16432074|REF_RGD_ID:1582641 |
MMP9 | Dog | Acute Lung Injury | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23040778|REF_RGD_ID:13207316 |
MMP9 | Dog | Acute Otitis Media | | ISO | Mmp9 (Mus musculus) | 9068941 | mRNA:increased expression:middle ear (mouse) | RGD | PMID:21889218|REF_RGD_ID:127284853 |
MMP9 | Dog | adrenoleukodystrophy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:cerebrospinal fluid | RGD | PMID:23185624|REF_RGD_ID:13204814 |
MMP9 | Dog | adult respiratory distress syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:lung | RGD | PMID:21211006|REF_RGD_ID:5129208 |
MMP9 | Dog | Albuminuria | onset | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Diabetes Mellitus, Type 2; protein:increased expression:plasma (human) | RGD | PMID:9774113|REF_RGD_ID:7207214 |
MMP9 | Dog | alcohol use disorder | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:24966898|REF_RGD_ID:13207311 |
MMP9 | Dog | Alcoholic Liver Diseases | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:liver | RGD | PMID:17374579|REF_RGD_ID:1642042 |
MMP9 | Dog | allergic contact dermatitis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:skin, lymph node | RGD | PMID:16977379|REF_RGD_ID:2325935 |
MMP9 | Dog | allergic contact dermatitis | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:10359808|PMID:10415717|REF_RGD_ID:8547869|REF_RGD_ID:8693317 |
MMP9 | Dog | Alveolar Bone Loss | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with periodontal disease | RGD | PMID:33364953|REF_RGD_ID:329956421 |
MMP9 | Dog | Alzheimer's disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma (human) | RGD | PMID:17697439|REF_RGD_ID:7207052 |
MMP9 | Dog | amyotrophic lateral sclerosis | severity | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum, cerebrospinal fluid (human) | RGD | PMID:19796283|REF_RGD_ID:7207054 |
MMP9 | Dog | amyotrophic lateral sclerosis | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:skin of body, spinal cord | RGD | PMID:20441996|REF_RGD_ID:13204793 |
MMP9 | Dog | angle-closure glaucoma | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP:promoter:-1562C>T (human) | RGD | PMID:23441116|REF_RGD_ID:8549724 |
MMP9 | Dog | angle-closure glaucoma | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP: :rs2664538 (human) | RGD | PMID:17110919|REF_RGD_ID:8547816 |
MMP9 | Dog | angle-closure glaucoma | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNPs: :rs17576, rs3918249 (human) | RGD | PMID:21655354|REF_RGD_ID:8547830 |
MMP9 | Dog | angle-closure glaucoma | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP: :c.836A>G (rs17576) (human) | RGD | PMID:23441116|REF_RGD_ID:8549724 |
MMP9 | Dog | Animal Mammary Neoplasms | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23714264|REF_RGD_ID:8547831 |
MMP9 | Dog | anodontia | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP: :rs17576 (human) | RGD | PMID:24351915|REF_RGD_ID:13204812 |
MMP9 | Dog | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased activity:urine (human) | RGD | PMID:17898039|REF_RGD_ID:7207083 |
MMP9 | Dog | aortic dissection | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | Apolipoprotein E knockout | RGD | PMID:33403385|REF_RGD_ID:156420156 |
MMP9 | Dog | Arterial Injury | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:22552115|REF_RGD_ID:6484736 |
MMP9 | Dog | arteriosclerosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16317521|REF_RGD_ID:1582628 |
MMP9 | Dog | arteriosclerosis | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15823277|REF_RGD_ID:1580550 |
MMP9 | Dog | Arteriovenous Fistula | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:17398390|REF_RGD_ID:1642040 |
MMP9 | Dog | Arteriovenous Fistula | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23924957|REF_RGD_ID:13204800 |
MMP9 | Dog | arteriovenous malformation | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16720380|REF_RGD_ID:1582655 |
MMP9 | Dog | asthma | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP: : rs2664538(human) | RGD | PMID:20181264|REF_RGD_ID:5130859 |
MMP9 | Dog | asthma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:lung | RGD | PMID:19361849|REF_RGD_ID:5129687 |
MMP9 | Dog | asthma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:21439806|REF_RGD_ID:5129204 |
MMP9 | Dog | asthma | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:lung | RGD | PMID:16191269|REF_RGD_ID:2325953 |
MMP9 | Dog | asthma | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:19940022|REF_RGD_ID:5129522 |
MMP9 | Dog | atopic dermatitis | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:27776525|REF_RGD_ID:13204759 |
MMP9 | Dog | atrial fibrillation | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:papillary muscle of left ventricle | RGD | PMID:19734590|REF_RGD_ID:8549736 |
MMP9 | Dog | atrial fibrillation | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:18194448|REF_RGD_ID:8547896 |
MMP9 | Dog | attention deficit hyperactivity disorder | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:24633733|REF_RGD_ID:13204849 |
MMP9 | Dog | autism spectrum disorder | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:brain | RGD | PMID:25466251|REF_RGD_ID:13204755 |
MMP9 | Dog | autism spectrum disorder | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:25466251|REF_RGD_ID:13204755 |
MMP9 | Dog | autoimmune lymphoproliferative syndrome | disease_progression | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:21376533|REF_RGD_ID:13204846 |
MMP9 | Dog | autosomal dominant polycystic kidney disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma (human) | RGD | PMID:10644865|REF_RGD_ID:7207194 |
MMP9 | Dog | bacterial meningitis | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:10430840|REF_RGD_ID:8547971 |
MMP9 | Dog | bacterial pneumonia | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:bronchoalveolar lavage fluid | RGD | PMID:19535150|REF_RGD_ID:5129533 |
MMP9 | Dog | bacterial pneumonia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:17202364|REF_RGD_ID:5130727 |
MMP9 | Dog | Behcet's disease | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:17949555|REF_RGD_ID:8657044 |
MMP9 | Dog | Behcet's disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma, platelets | RGD | PMID:22116092|REF_RGD_ID:8547820 |
MMP9 | Dog | brain edema | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Cerebral Hemorrhage | RGD | PMID:20541575|REF_RGD_ID:5490126 |
MMP9 | Dog | brain infarction | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16599837|REF_RGD_ID:1582617 |
MMP9 | Dog | Brain Injuries | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16671440|REF_RGD_ID:1582656 |
MMP9 | Dog | Brain Injuries | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:24661104|REF_RGD_ID:13207312 |
MMP9 | Dog | brain ischemia | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16846501|REF_RGD_ID:1582611 |
MMP9 | Dog | Breast Neoplasms | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNPs, haplotype:rs17577, rs3787268 (human) | RGD | PMID:23570558|REF_RGD_ID:8547827 |
MMP9 | Dog | Breast Neoplasms | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:21159820|REF_RGD_ID:8547837 |
MMP9 | Dog | Breast Neoplasms | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:18172859|REF_RGD_ID:2290343 |
MMP9 | Dog | Breast Neoplasms | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNPs:promoter, CDS:rs3918241, rs2274756 (p.R668Q) (human) | RGD | PMID:20725776|REF_RGD_ID:8547893 |
MMP9 | Dog | Breast Neoplasms | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15538048|PMID:21151179|REF_RGD_ID:8547818|REF_RGD_ID:8547839 |
MMP9 | Dog | Bronchial Hyperreactivity | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:19940022|REF_RGD_ID:5129522 |
MMP9 | Dog | bronchiectasis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression: : | RGD | PMID:19725099|REF_RGD_ID:5129526 |
MMP9 | Dog | bronchiolitis obliterans | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression, increased activity:bronchoalveolar lavage fluid | RGD | PMID:20417130|REF_RGD_ID:5130759 |
MMP9 | Dog | bronchopulmonary dysplasia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:19097983|REF_RGD_ID:5129685 |
MMP9 | Dog | bullous pemphigoid | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:9687525|REF_RGD_ID:8547843 |
MMP9 | Dog | Burns | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:brain | RGD | PMID:17156757|REF_RGD_ID:1642051 |
MMP9 | Dog | CAKUT2 | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:27448803|REF_RGD_ID:13204792 |
MMP9 | Dog | Cardiac Fibrosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Arthritis, Experimental | RGD | PMID:23905389|REF_RGD_ID:13204857 |
MMP9 | Dog | Cardiac Fibrosis | | ISO | Mmp9 (Mus musculus) | 9068941 | associated with Cardiomegaly;mRNA:increased expression:heart | RGD | PMID:23144938|REF_RGD_ID:13204817 |
MMP9 | Dog | Cardiomegaly | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:heart left ventricle | RGD | PMID:17207419|REF_RGD_ID:1642047 |
MMP9 | Dog | cardiomyopathy | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16681691|REF_RGD_ID:1581215 |
MMP9 | Dog | cardiomyopathy | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:21810612|REF_RGD_ID:13204757 |
MMP9 | Dog | carotid artery disease | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16339461|REF_RGD_ID:1582626 |
MMP9 | Dog | Carotid Artery Injuries | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:9327785|REF_RGD_ID:8547910 |
MMP9 | Dog | Carotid Atherosclerosis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:carotid artery segment (human) | RGD | PMID:16774841|REF_RGD_ID:329845567 |
MMP9 | Dog | Cerebral Hemorrhage | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:17021183|REF_RGD_ID:1582637 |
MMP9 | Dog | childhood absence epilepsy | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:20303372|REF_RGD_ID:8547934 |
MMP9 | Dog | cholangiocarcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:bile duct | RGD | PMID:16463672|REF_RGD_ID:2325856 |
MMP9 | Dog | cholangiocarcinoma | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:bile duct | RGD | PMID:15213623|REF_RGD_ID:2324667 |
MMP9 | Dog | cholangiocarcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:bile duct | RGD | PMID:15213623|REF_RGD_ID:2324667 |
MMP9 | Dog | cholesteatoma | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:19484988|REF_RGD_ID:8657059 |
MMP9 | Dog | cholesteatoma of middle ear | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15620146|REF_RGD_ID:8547870 |
MMP9 | Dog | chorioamnionitis | severity | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:respiratory system fluid/secretion | RGD | PMID:12712078|REF_RGD_ID:13204828 |
MMP9 | Dog | Choroidal Neovascularization | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:25314292|REF_RGD_ID:13207327 |
MMP9 | Dog | Choroidal Neovascularization | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma | RGD | PMID:17304258|REF_RGD_ID:8657061 |
MMP9 | Dog | Choroidal Neovascularization | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:12368198|REF_RGD_ID:8547840 |
MMP9 | Dog | chronic inflammatory demyelinating polyradiculoneuropathy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:sural nerve | RGD | PMID:10408538|REF_RGD_ID:13204856 |
MMP9 | Dog | chronic obstructive pulmonary disease | severity | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:polymorphism:promoter:-1562C-->T (human) | RGD | PMID:18619044|REF_RGD_ID:5130149 |
MMP9 | Dog | chronic obstructive pulmonary disease | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:25842729|REF_RGD_ID:13207319 |
MMP9 | Dog | chronic obstructive pulmonary disease | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:polymorphism: :-1562C-->T (human) | RGD | PMID:20160424|REF_RGD_ID:5129494 |
MMP9 | Dog | chronic obstructive pulmonary disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:19411568|REF_RGD_ID:5129553 |
MMP9 | Dog | Chronic Periodontitis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Atherosclerosis | RGD | PMID:24820783|REF_RGD_ID:13207324 |
MMP9 | Dog | chronic ulcer of skin | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Scleroderma, Systemic in males;DNA:SNP:promoter:-1562C>T (rs3918242) (human) | RGD | PMID:21455563|REF_RGD_ID:8547865 |
MMP9 | Dog | Cicatrix | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Wounds, Penetrating | RGD | PMID:23076999|REF_RGD_ID:13207326 |
MMP9 | Dog | cognitive disorder | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:brain | RGD | PMID:22363061|REF_RGD_ID:8694114 |
MMP9 | Dog | colon adenocarcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:colon (human) | RGD | PMID:22419013|REF_RGD_ID:153344572 |
MMP9 | Dog | Colonic Neoplasms | disease_progression | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:colon | RGD | PMID:20428773|REF_RGD_ID:2325778 |
MMP9 | Dog | Colonic Neoplasms | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression, increased activity:large intestine mucosa | RGD | PMID:21268133|REF_RGD_ID:5135051 |
MMP9 | Dog | colorectal cancer | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expresion:colorectum (human) | RGD | PMID:21839130|REF_RGD_ID:152985531 |
MMP9 | Dog | colorectal cancer | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | human cells in mouse model | RGD | PMID:32682784|REF_RGD_ID:153297782 |
MMP9 | Dog | Colorectal Neoplasms | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23149858|REF_RGD_ID:8657112 |
MMP9 | Dog | congestive heart failure | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16952784|REF_RGD_ID:1582647 |
MMP9 | Dog | congestive heart failure | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Hypertension, Pulmonary; protein:increased expression:heart | RGD | PMID:17913382|REF_RGD_ID:5130174 |
MMP9 | Dog | congestive heart failure | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:11342481|REF_RGD_ID:7207137 |
MMP9 | Dog | congestive heart failure | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:heart left ventricle, plasma | RGD | PMID:20606426|REF_RGD_ID:8694112 |
MMP9 | Dog | conjunctivochalasis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:conjunctiva | RGD | PMID:20019361|REF_RGD_ID:8693314 |
MMP9 | Dog | coronary artery disease | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:26261622|REF_RGD_ID:11344965 |
MMP9 | Dog | coronary artery disease | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15191941|REF_RGD_ID:1582644 |
MMP9 | Dog | crescentic glomerulonephritis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:renal cortex (rat) | RGD | PMID:16046515|REF_RGD_ID:2313720 |
MMP9 | Dog | cystic fibrosis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:25545245|REF_RGD_ID:13204794 |
MMP9 | Dog | cystic fibrosis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:bronchoalveolar lavage fluid | RGD | PMID:17526676|REF_RGD_ID:5130723 |
MMP9 | Dog | dermatomyositis | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:skeletal muscle | RGD | PMID:11157561|REF_RGD_ID:8547876 |
MMP9 | Dog | Diabetic Foot | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:22688339|REF_RGD_ID:8547813 |
MMP9 | Dog | Diabetic Nephropathies | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Diabetes Mellitus, Type 2;DNA:repeat:promoter | RGD | PMID:11576356|REF_RGD_ID:8547866 |
MMP9 | Dog | Diabetic Nephropathies | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Diabetes Mellitus, Experimental | RGD | PMID:23384615|REF_RGD_ID:13204971 |
MMP9 | Dog | diabetic retinopathy | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16643893|REF_RGD_ID:1582616 |
MMP9 | Dog | diabetic retinopathy | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Diabetes Mellitus, Type 2 | RGD | PMID:10374894|REF_RGD_ID:8547815 |
MMP9 | Dog | diabetic retinopathy | | ISO | Mmp9 (Mus musculus) | 9068941 | associated with Diabetes Mellitus, Experimental | RGD | PMID:21933988|REF_RGD_ID:8547857 |
MMP9 | Dog | Down syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:24519975|REF_RGD_ID:13204810 |
MMP9 | Dog | Duchenne muscular dystrophy | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23977226|REF_RGD_ID:13204809 |
MMP9 | Dog | ductal carcinoma in situ | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:breast | RGD | PMID:14744773|REF_RGD_ID:2290436 |
MMP9 | Dog | Embolism | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16720380|REF_RGD_ID:1582655 |
MMP9 | Dog | Emphysema | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:22633097|REF_RGD_ID:13207325 |
MMP9 | Dog | endometrial carcinoma | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:endometrium | RGD | PMID:12487935|REF_RGD_ID:2298523 |
MMP9 | Dog | endometriosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:endometrium | RGD | PMID:20085636|REF_RGD_ID:2325792 |
MMP9 | Dog | epidermolysis bullosa simplex | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:23894602|REF_RGD_ID:13204851 |
MMP9 | Dog | epilepsy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:cerebral cortex, hippocampus | RGD | PMID:23182966|REF_RGD_ID:13204763 |
MMP9 | Dog | esophagus adenocarcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:esophagus | RGD | PMID:25562781|REF_RGD_ID:13204790 |
MMP9 | Dog | esophagus squamous cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased activity: esophagus | RGD | PMID:24789592|REF_RGD_ID:152600903 |
MMP9 | Dog | exfoliation syndrome | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:insertion: :p.Q279R (rs17576) (human) | RGD | PMID:20808730|REF_RGD_ID:8549725 |
MMP9 | Dog | Experimental Arthritis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:cartilage, serum, synovial fluid | RGD | PMID:17463159|REF_RGD_ID:1642035 |
MMP9 | Dog | Experimental Autoimmune Encephalomyelitis | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:multiple tissues | RGD | PMID:20810258|REF_RGD_ID:13204762 |
MMP9 | Dog | Experimental Autoimmune Encephalomyelitis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:22800566|REF_RGD_ID:8547936 |
MMP9 | Dog | Experimental Autoimmune Encephalomyelitis | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:24797785|REF_RGD_ID:13204801 |
MMP9 | Dog | Experimental Autoimmune Encephalomyelitis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:9549496|REF_RGD_ID:8547909 |
MMP9 | Dog | Experimental Autoimmune Neuritis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:9546322|REF_RGD_ID:9685357 |
MMP9 | Dog | Experimental Colitis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23323009|REF_RGD_ID:13207328 |
MMP9 | Dog | Experimental Diabetes Mellitus | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23423566|REF_RGD_ID:8547881 |
MMP9 | Dog | Experimental Diabetes Mellitus | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:retina | RGD | PMID:23423566|REF_RGD_ID:8547881 |
MMP9 | Dog | Experimental Diabetes Mellitus | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23089644|REF_RGD_ID:8547974 |
MMP9 | Dog | Experimental Diabetes Mellitus | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:kidney | RGD | PMID:17569353|REF_RGD_ID:2290354 |
MMP9 | Dog | Experimental Liver Neoplasms | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression, increased activity:liver | RGD | PMID:19539802|REF_RGD_ID:2325734 |
MMP9 | Dog | Experimental Liver Neoplasms | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:19528495|REF_RGD_ID:2325736 |
MMP9 | Dog | Experimental Mammary Neoplasms | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23359979|REF_RGD_ID:8657038 |
MMP9 | Dog | Experimental Mammary Neoplasms | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:mammary gland | RGD | PMID:19725228|REF_RGD_ID:2325823 |
MMP9 | Dog | facial paralysis | | ISO | Mmp9 (Mus musculus) | 9068941 | associated with Herpes Simplex;mRNA, protein:increased expression:facial VII nucleus | RGD | PMID:23817985|REF_RGD_ID:8547852 |
MMP9 | Dog | familial hyperlipidemia | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Diabetes Mellitus, Type 2 | RGD | PMID:16490430|REF_RGD_ID:1642030 |
MMP9 | Dog | Febrile Seizures | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with influenza; protein:increased expression:serum | RGD | PMID:17529876|REF_RGD_ID:5130920 |
MMP9 | Dog | Fibrosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:liver | RGD | PMID:20108118|REF_RGD_ID:2325790 |
MMP9 | Dog | Focal Cortical Dysplasia of Taylor | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:cerebral cortex | RGD | PMID:22459050|REF_RGD_ID:8547829 |
MMP9 | Dog | focal segmental glomerulosclerosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression, increased activity:kidney | RGD | PMID:19357873|REF_RGD_ID:2325738 |
MMP9 | Dog | fragile X syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:brain | RGD | PMID:25466251|REF_RGD_ID:13204755 |
MMP9 | Dog | fragile X syndrome | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:26850918|REF_RGD_ID:11572344 |
MMP9 | Dog | gastric ulcer | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:stomach secretion | RGD | PMID:17603938|REF_RGD_ID:1642033 |
MMP9 | Dog | glaucoma | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16185954|REF_RGD_ID:8547817 |
MMP9 | Dog | glioblastoma | severity | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:brain (human) | RGD | PMID:7616276|REF_RGD_ID:7207145 |
MMP9 | Dog | glioblastoma | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:12439751|REF_RGD_ID:8547973 |
MMP9 | Dog | glomerulosclerosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Obesity;mRNA:decreased expression:glomerulus | RGD | PMID:9300240|REF_RGD_ID:8547929 |
MMP9 | Dog | glomerulosclerosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Hyperhomocysteinemia | RGD | PMID:20406136|REF_RGD_ID:7207203 |
MMP9 | Dog | Gouty Arthritis | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:14687896|REF_RGD_ID:8547877 |
MMP9 | Dog | heart valve disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:24093773|REF_RGD_ID:13204818 |
MMP9 | Dog | Hemorrhagic Shock | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16141011|REF_RGD_ID:401717565 |
MMP9 | Dog | hepatic veno-occlusive disease | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:blood, liver, lung | RGD | PMID:23303633|REF_RGD_ID:13204885 |
MMP9 | Dog | hepatocellular carcinoma | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:21681821|REF_RGD_ID:8547864 |
MMP9 | Dog | Herpes Simplex Encephalitis | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased activity:brain | RGD | PMID:15364410|REF_RGD_ID:8547868 |
MMP9 | Dog | Herpes Simplex Encephalitis | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:20483026|REF_RGD_ID:8547867 |
MMP9 | Dog | Human Influenza | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased activity:lung, heart, brain | RGD | PMID:20299740|REF_RGD_ID:5130855 |
MMP9 | Dog | Huntington's disease | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:striatum | RGD | PMID:21175737|REF_RGD_ID:13204827 |
MMP9 | Dog | hyperglycemia | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Brain Ischemia | RGD | PMID:17272778|REF_RGD_ID:1642027 |
MMP9 | Dog | hyperhomocysteinemia | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:24739303|REF_RGD_ID:13204791 |
MMP9 | Dog | Hyperlipoproteinemia Type II | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:16280123|REF_RGD_ID:1642031 |
MMP9 | Dog | Hyperoxia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:18658276|REF_RGD_ID:5130148 |
MMP9 | Dog | Hyperoxia | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:decreased expression, decreased activity:lung | RGD | PMID:15128910|REF_RGD_ID:8547972 |
MMP9 | Dog | Hyperoxic Lung Injury | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:25760549|REF_RGD_ID:13204816 |
MMP9 | Dog | hypertension | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16840178|REF_RGD_ID:1582612 |
MMP9 | Dog | hypertension | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:17977875|REF_RGD_ID:2290351 |
MMP9 | Dog | hypertension | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:decreased expression:internal mammary artery | RGD | PMID:15363819|REF_RGD_ID:1582532 |
MMP9 | Dog | hypertension | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Aneurysm, Dissecting;DNA:polymorphism:promoter:-1562C>T | RGD | PMID:16780738|REF_RGD_ID:1642029 |
MMP9 | Dog | hypertrophic cardiomyopathy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma | RGD | PMID:18585501|REF_RGD_ID:5130889 |
MMP9 | Dog | ileus | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:jejunum, colon, peritoneal fluid | RGD | PMID:23079570|REF_RGD_ID:8547906 |
MMP9 | Dog | Inflammation | | ISO | Mmp9 (Mus musculus) | 9068941 | mRNA:increased expression:skin | RGD | PMID:16489579|REF_RGD_ID:8547835 |
MMP9 | Dog | interstitial lung disease | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:20185904|REF_RGD_ID:5130857 |
MMP9 | Dog | interstitial lung disease | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Sclerodema, systemic; protein:increased expression:bronchoalveolar lavage fluid | RGD | PMID:17643278|REF_RGD_ID:5130207 |
MMP9 | Dog | intracranial aneurysm | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:artery | RGD | PMID:17122420|REF_RGD_ID:1642055 |
MMP9 | Dog | intracranial aneurysm | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:artery | RGD | PMID:32602008|REF_RGD_ID:155882593 |
MMP9 | Dog | intracranial aneurysm | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16961137|REF_RGD_ID:1582646 |
MMP9 | Dog | intracranial aneurysm | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:21937941|REF_RGD_ID:13204858 |
MMP9 | Dog | intracranial aneurysm | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:9310982|REF_RGD_ID:13204853 |
MMP9 | Dog | intracranial aneurysm | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Diabetes Mellitus, Experimental | RGD | PMID:23844137|REF_RGD_ID:8547935 |
MMP9 | Dog | intracranial aneurysm | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:blood vessel | RGD | PMID:17569872|REF_RGD_ID:2290352 |
MMP9 | Dog | ischemia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:15047130|REF_RGD_ID:1582640 |
MMP9 | Dog | Kawasaki disease | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:18311803|REF_RGD_ID:8547899 |
MMP9 | Dog | Kawasaki disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:blood | RGD | PMID:12626459|REF_RGD_ID:1580170 |
MMP9 | Dog | kidney disease | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:decreased expression:kidney | RGD | PMID:17392157|REF_RGD_ID:1642041 |
MMP9 | Dog | Laryngeal Neoplasms | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:17786346|REF_RGD_ID:5130203 |
MMP9 | Dog | Liver Injury | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:liver (rat) | RGD | PMID:10933221|REF_RGD_ID:7207088 |
MMP9 | Dog | Liver Reperfusion Injury | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Fatty Liver;mRNA, protein:decreased expression, decreased activity:liver | RGD | PMID:17255325|REF_RGD_ID:8547976 |
MMP9 | Dog | lung disease | | ISO | Mmp9 (Mus musculus) | 9068941 | Ventilator-Induced Lung Injury | RGD | PMID:18223162|REF_RGD_ID:5130156 |
MMP9 | Dog | lung disease | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | lung injury; mRNA, protein:increased expression:lung | RGD | PMID:19545667|REF_RGD_ID:5129531 |
MMP9 | Dog | lung disease | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:bronchoalveolar lavage fluid | RGD | PMID:20335295|REF_RGD_ID:5129490 |
MMP9 | Dog | lung disease | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | lung injury associated with pancreatitis, acute necrotizing | RGD | PMID:19494493|REF_RGD_ID:5129548 |
MMP9 | Dog | Lung Neoplasms | | ISO | MMP9 (Homo sapiens) | 9068941 | Pulmonary Sclerosing Hemangioma; mRNA, protein:increased expression:lung | RGD | PMID:17914564|REF_RGD_ID:5130173 |
MMP9 | Dog | Lung Neoplasms | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with lung disease; protein:decreased expression:pleural fluid | RGD | PMID:20216542|REF_RGD_ID:5129491 |
MMP9 | Dog | lung non-small cell carcinoma | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:20704821|REF_RGD_ID:5129215 |
MMP9 | Dog | Lung Reperfusion Injury | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased activity:lung | RGD | PMID:18694576|REF_RGD_ID:5129703 |
MMP9 | Dog | lymphangioleiomyomatosis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum, plasma | RGD | PMID:18760908|REF_RGD_ID:5129697 |
MMP9 | Dog | Lymphatic Metastasis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Endometrial Neoplasms;protein:increased expression:endometrium | RGD | PMID:12487935|REF_RGD_ID:2298523 |
MMP9 | Dog | Lymphatic Metastasis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Tongue Neoplasms | RGD | PMID:23107277|REF_RGD_ID:8547824 |
MMP9 | Dog | Lymphatic Metastasis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Carcinoma, Non-Small-Cell Lung;protein:increased expression:serum | RGD | PMID:20704821|REF_RGD_ID:5129215 |
MMP9 | Dog | macular degeneration | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:22490043|REF_RGD_ID:7829793 |
MMP9 | Dog | macular degeneration | severity | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:vitreous humor | RGD | PMID:22773904|REF_RGD_ID:10053644 |
MMP9 | Dog | Malignant Pleural Effusions | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with pleurisy; protein:decreased activity:pleura | RGD | PMID:17611666|REF_RGD_ID:5130711 |
MMP9 | Dog | Marfan syndrome | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:18178469|REF_RGD_ID:13204796 |
MMP9 | Dog | membranous glomerulonephritis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:8613533|REF_RGD_ID:8547919 |
MMP9 | Dog | meningococcal meningitis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:10430840|REF_RGD_ID:8547971 |
MMP9 | Dog | metabolic dysfunction-associated steatohepatitis | | ISO | Mmp9 (Mus musculus) | 9068941 | mRNA:altered expression:liver (mouse) | RGD | PMID:24294355|REF_RGD_ID:407446378 |
MMP9 | Dog | Metaphyseal Anadysplasia | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:missense mutations: :p.M1K (c.21T>A)(human) | RGD | PMID:19615667|REF_RGD_ID:13204811 |
MMP9 | Dog | middle cerebral artery infarction | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:24842554|REF_RGD_ID:13204729 |
MMP9 | Dog | Multiple Organ Failure | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased activity:liver, lung, spleen (mouse) | RGD | PMID:15259001|REF_RGD_ID:7207133 |
MMP9 | Dog | Multiple Organ Failure | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:multiple tissues | RGD | PMID:21964536|REF_RGD_ID:8547897 |
MMP9 | Dog | multiple sclerosis | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:blood, mononuclear cell | RGD | PMID:23401127|REF_RGD_ID:13204754 |
MMP9 | Dog | multiple sclerosis | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP:promoter:-1562C>T (human) | RGD | PMID:19628284|REF_RGD_ID:13204795 |
MMP9 | Dog | multiple sclerosis | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:repeat, SNP:promoter | RGD | PMID:10713364|REF_RGD_ID:13204826 |
MMP9 | Dog | multiple sclerosis | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP, repeat:promoter:-1562C>T (human) | RGD | PMID:20471697|REF_RGD_ID:13204848 |
MMP9 | Dog | Mycoplasma Infections | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:17217365|REF_RGD_ID:1642046 |
MMP9 | Dog | myocardial infarction | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16845718|REF_RGD_ID:1582653 |
MMP9 | Dog | myocardial infarction | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression, increased activity:heart left ventricle (rat) | RGD | PMID:8531210|REF_RGD_ID:7207198 |
MMP9 | Dog | myocardial infarction | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:heart left ventricle | RGD | PMID:25520329|REF_RGD_ID:13204799 |
MMP9 | Dog | myocardial infarction | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:14729404|REF_RGD_ID:1582639 |
MMP9 | Dog | myocardial infarction | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:coronary artery, plasma (human) | RGD | PMID:15118287|REF_RGD_ID:1582645 |
MMP9 | Dog | myocardial infarction | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:snps:promoter, exon:g.-1562C>T, p.R279Q (rs3918242, rs2664538) (human) | RGD | PMID:17893005|REF_RGD_ID:7207049 |
MMP9 | Dog | myocarditis | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16533694|REF_RGD_ID:1582352 |
MMP9 | Dog | Nasal Polyps | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:23987197|REF_RGD_ID:8657056 |
MMP9 | Dog | Nasal Polyps | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Rhinosinusitis;mRNA:increased expression:nasal cavity mucosa | RGD | PMID:23064462|REF_RGD_ID:8549735 |
MMP9 | Dog | Nasal Polyps | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Asthma, Aspirin-Induced; DNA:polymorphism:promoter: -1562C>T (human) | RGD | PMID:19958602|REF_RGD_ID:5130861 |
MMP9 | Dog | Neointima | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23344254|REF_RGD_ID:13207403 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | Mmp9 (Mus musculus) | 9068941 | associated with Mammary Neoplasms, Animal; associated with Arthritis, Experimental | RGD | PMID:21859454|REF_RGD_ID:5510000 |
MMP9 | Dog | Neoplasm Metastasis | severity | ISO | MMP9 (Homo sapiens) | 9068941 | associated with osteosarcoma;protein:increased expression:bone (human) | RGD | PMID:26546437|REF_RGD_ID:152023746 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:8912869|REF_RGD_ID:8547928 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with skin melanoma;DNA:missense mutation:cds:p.Q279R (human) | RGD | PMID:17346338|REF_RGD_ID:8547886 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Mammary Neoplasms, Animal;protein:increased expression:brain | RGD | PMID:16158251|REF_RGD_ID:8547884 |
MMP9 | Dog | Neoplasm Metastasis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | associated with carcinoma, pancreatic ductal; protein:increased expression:pancreas | RGD | PMID:17378244|REF_RGD_ID:2325855 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | Mmp9 (Mus musculus) | 9068941 | associated with Mammary Neoplasms, Animal | RGD | PMID:18676849|REF_RGD_ID:8547878 |
MMP9 | Dog | Neoplasm Metastasis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | associated with pancreatic cancer; protein:increased expression, increased activity:pancreas | RGD | PMID:12173379|REF_RGD_ID:2325749 |
MMP9 | Dog | Neoplasm Metastasis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Melanoma | RGD | PMID:16033831|REF_RGD_ID:8547861 |
MMP9 | Dog | Nephrogenic Fibrosing Dermopathy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:skin (human) | RGD | PMID:20708474|REF_RGD_ID:7207047 |
MMP9 | Dog | neuromyelitis optica | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:21621856|REF_RGD_ID:8547883 |
MMP9 | Dog | obesity | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma | RGD | PMID:17512313|REF_RGD_ID:1642026 |
MMP9 | Dog | obstructive sleep apnea | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:19652426|REF_RGD_ID:5130877 |
MMP9 | Dog | obstructive sleep apnea | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:palatopharyngeal muscle | RGD | PMID:20836084|REF_RGD_ID:5129212 |
MMP9 | Dog | ocular hypertension | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:eye | RGD | PMID:19575923|REF_RGD_ID:2325732 |
MMP9 | Dog | osteoarthritis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:synovial fluid, serum (human) | RGD | PMID:15194590|REF_RGD_ID:7207131 |
MMP9 | Dog | osteoporosis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with osteoporosis; protein:increased expression:serum | RGD | PMID:19411568|REF_RGD_ID:5129553 |
MMP9 | Dog | pancreatic cancer | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:pancreas | RGD | PMID:7635566|REF_RGD_ID:2325766 |
MMP9 | Dog | pancreatic cancer | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:19629003|REF_RGD_ID:2325831 |
MMP9 | Dog | pancreatic cancer | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:18030366|PMID:18445772|REF_RGD_ID:2325849|REF_RGD_ID:2325854 |
MMP9 | Dog | pancreatic ductal carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:pancreas, serum | RGD | PMID:18706098|REF_RGD_ID:2325844 |
MMP9 | Dog | pancreatic ductal carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:blood | RGD | PMID:20332475|REF_RGD_ID:2325830 |
MMP9 | Dog | paracoccidioidomycosis | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:19765107|REF_RGD_ID:8657058 |
MMP9 | Dog | Parkinsonism | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:15075439|REF_RGD_ID:13204850 |
MMP9 | Dog | Pathologic Constriction | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16159601|REF_RGD_ID:1582642 |
MMP9 | Dog | Perennial Allergic Rhinitis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:nasal mucosa: | RGD | PMID:19786210|REF_RGD_ID:5130872 |
MMP9 | Dog | pleural tuberculosis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:pleura: | RGD | PMID:18715875|REF_RGD_ID:5129700 |
MMP9 | Dog | Pneumococcal Meningitis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:cerebrospinal fluid | RGD | PMID:17371820|REF_RGD_ID:1642043 |
MMP9 | Dog | Pneumococcal Meningitis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:24419461|REF_RGD_ID:8657111 |
MMP9 | Dog | pneumonia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:18007984|REF_RGD_ID:5130157 |
MMP9 | Dog | polymyositis | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:skeletal muscle | RGD | PMID:11157561|REF_RGD_ID:8547876 |
MMP9 | Dog | Polypoidal Choroidal Vasculopathy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:23559867|REF_RGD_ID:8547885 |
MMP9 | Dog | pre-eclampsia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:23776237|REF_RGD_ID:13204787 |
MMP9 | Dog | pre-eclampsia | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA, protein:decreased expression:placenta | RGD | PMID:17083831|REF_RGD_ID:2290399 |
MMP9 | Dog | primary biliary cholangitis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:20056896|REF_RGD_ID:8552731 |
MMP9 | Dog | primary open angle glaucoma | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:insertion: :p.Q279R (rs17576) (human) | RGD | PMID:20808730|REF_RGD_ID:8549725 |
MMP9 | Dog | primary progressive multiple sclerosis | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:14504963|REF_RGD_ID:13204808 |
MMP9 | Dog | Pseudomonas Aeruginosa Keratitis | treatment | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16384971|REF_RGD_ID:8547891 |
MMP9 | Dog | pterygium | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:19420332|REF_RGD_ID:8657043 |
MMP9 | Dog | pulmonary embolism | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16304337|REF_RGD_ID:1582630 |
MMP9 | Dog | pulmonary emphysema | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased activity:lung | RGD | PMID:19897563|REF_RGD_ID:4892307 |
MMP9 | Dog | pulmonary emphysema | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:14605041|REF_RGD_ID:8547887 |
MMP9 | Dog | pulmonary emphysema | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:18408070|REF_RGD_ID:5130151 |
MMP9 | Dog | pulmonary fibrosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression:lung, plasma | RGD | PMID:17121240|REF_RGD_ID:1642054 |
MMP9 | Dog | pulmonary fibrosis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23318412|REF_RGD_ID:13204970 |
MMP9 | Dog | pulmonary hypertension | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:21063214|REF_RGD_ID:5129210 |
MMP9 | Dog | pulmonary hypertension | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23087098|REF_RGD_ID:7207217 |
MMP9 | Dog | pulmonary hypertension | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:18355767|REF_RGD_ID:5130155 |
MMP9 | Dog | pulmonary hypertension | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Pulmonary Embolism;protein:increased expression:lung, plasma | RGD | PMID:17133179|REF_RGD_ID:1642053 |
MMP9 | Dog | pulmonary hypertension | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Heart Failure, Congestive;protein:decreased expression:monocyte | RGD | PMID:16867026|REF_RGD_ID:1642028 |
MMP9 | Dog | pulmonary tuberculosis | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16982845|REF_RGD_ID:5130746 |
MMP9 | Dog | pyoderma gangrenosum | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:skin | RGD | PMID:21658319|REF_RGD_ID:8657060 |
MMP9 | Dog | relapsing-remitting multiple sclerosis | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16412833|REF_RGD_ID:13204825 |
MMP9 | Dog | renal cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:kidney | RGD | PMID:18035688|REF_RGD_ID:2290358 |
MMP9 | Dog | renal fibrosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23006043|REF_RGD_ID:13204847 |
MMP9 | Dog | renal hypertension | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:12923405|REF_RGD_ID:1302333 |
MMP9 | Dog | Reperfusion Injury | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:limb muscle (mouse) | RGD | PMID:16251419|REF_RGD_ID:1582631 |
MMP9 | Dog | Reperfusion Injury | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with lung injury; mRNA, protein:increased expression:lung | RGD | PMID:19545667|REF_RGD_ID:5129531 |
MMP9 | Dog | Reperfusion Injury | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16551680|REF_RGD_ID:1582618 |
MMP9 | Dog | Respiratory Sounds | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:brochoalveolar lavage fluid | RGD | PMID:18391843|REF_RGD_ID:5130916 |
MMP9 | Dog | respiratory syncytial virus infectious disease | | ISO | Mmp9 (Mus musculus) | 9068941 | mRNA, protein:increased expression, increased activity:bronchoalveolar lavage fluid | RGD | PMID:17254480|REF_RGD_ID:5130726 |
MMP9 | Dog | Respirovirus Infections | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression, increased activity:lung | RGD | PMID:16816895|REF_RGD_ID:5130923 |
MMP9 | Dog | retinal ischemia | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23537149|REF_RGD_ID:10755711 |
MMP9 | Dog | rheumatic heart disease | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16406300|REF_RGD_ID:1582623 |
MMP9 | Dog | rheumatoid arthritis | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16406300|REF_RGD_ID:1582623 |
MMP9 | Dog | Rhinosinusitis | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:23401274|REF_RGD_ID:8547880 |
MMP9 | Dog | Right Ventricular Hypertrophy | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | associated with Hypertension, Pulmonary; protein:increased expression:heart | RGD | PMID:17913382|REF_RGD_ID:5130174 |
MMP9 | Dog | rosacea | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:tear | RGD | PMID:10509643|REF_RGD_ID:8547821 |
MMP9 | Dog | sciatic neuropathy | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:25172308|REF_RGD_ID:13207330 |
MMP9 | Dog | Seasonal Allergic Rhinitis | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNPs:promoter, intron, cds:-1590C>T, 2127G>T, p.R668Q (rs3918242, rs2274755, rs17577) (human) | RGD | PMID:22237587|REF_RGD_ID:8547819 |
MMP9 | Dog | Sepsis | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23479197|REF_RGD_ID:8657110 |
MMP9 | Dog | sinusitis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression: : | RGD | PMID:20392482|REF_RGD_ID:5130763 |
MMP9 | Dog | Sjogren's syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased activity:saliva | RGD | PMID:9923658|REF_RGD_ID:8547858 |
MMP9 | Dog | Sjogren's syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15316122|REF_RGD_ID:8547814 |
MMP9 | Dog | skin melanoma | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:12404291|REF_RGD_ID:13204786 |
MMP9 | Dog | skin melanoma | disease progression | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP, missense mutations:promoter, cds:-1562C>T,p.R279Q, p.P574R (human) | RGD | PMID:17346338|REF_RGD_ID:8547886 |
MMP9 | Dog | Spinal Cord Injuries | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:25763638|REF_RGD_ID:12791993 |
MMP9 | Dog | squamous cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | mRNA:increased expression:tongue | RGD | PMID:18254958|REF_RGD_ID:8547895 |
MMP9 | Dog | squamous cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:nasal mucosa | RGD | PMID:21624249|REF_RGD_ID:8657057 |
MMP9 | Dog | squamous cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:middle ear | RGD | PMID:22178867|REF_RGD_ID:8547836 |
MMP9 | Dog | squamous cell carcinoma | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:11081634|REF_RGD_ID:8547854 |
MMP9 | Dog | status epilepticus | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:hippocampus, astrocyte, dendrite | RGD | PMID:17928157|REF_RGD_ID:8547922 |
MMP9 | Dog | stomach cancer | ameliorates | ISO | MMP9 (Homo sapiens) | 9068941 | human cells in mouse model | RGD | PMID:26432329|REF_RGD_ID:150520156 |
MMP9 | Dog | stomach carcinoma | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression, increased activity:stomach | RGD | PMID:20434464|REF_RGD_ID:2325777 |
MMP9 | Dog | Stroke | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16690896|REF_RGD_ID:1582615 |
MMP9 | Dog | Stroke | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased expression, increased activity:brain, plasma | RGD | PMID:19556529|REF_RGD_ID:2325825 |
MMP9 | Dog | Stroke | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:16051896|REF_RGD_ID:1582635 |
MMP9 | Dog | Sturge-Weber syndrome | severity | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:urine | RGD | PMID:23720035|REF_RGD_ID:13204823 |
MMP9 | Dog | Subarachnoid Hemorrhage | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:17410600|REF_RGD_ID:1642039 |
MMP9 | Dog | Sunburn | susceptibility | ISO | MMP9 (Homo sapiens) | 9068941 | associated with skin melanoma;DNA:missense mutations:cds:p.Q279R, p.R668Q (human) | RGD | PMID:17346338|REF_RGD_ID:8547886 |
MMP9 | Dog | Sweet syndrome | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:skin | RGD | PMID:21658319|REF_RGD_ID:8657060 |
MMP9 | Dog | systemic scleroderma | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15642145|REF_RGD_ID:1580577 |
MMP9 | Dog | Tachycardia, Atrioventricular Nodal Reentry | treatment | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:15175065|REF_RGD_ID:13204852 |
MMP9 | Dog | Takayasu's arteritis | disease_progression | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:23100088|REF_RGD_ID:8693315 |
MMP9 | Dog | temporal arteritis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased activity:temporal artery | RGD | PMID:17502363|REF_RGD_ID:8657040 |
MMP9 | Dog | temporal arteritis | no_association | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNPs:promoter, CDS:rs17576, rs3918242, rs3918252 (human) | RGD | PMID:18512818|REF_RGD_ID:8547902 |
MMP9 | Dog | temporal arteritis | | ISO | MMP9 (Homo sapiens) | 9068941 | DNA:SNP:CDS:rs2250889 (human) | RGD | PMID:18512818|REF_RGD_ID:8547902 |
MMP9 | Dog | temporal arteritis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:temporal artery (human) | RGD | PMID:15998676|REF_RGD_ID:1580575 |
MMP9 | Dog | temporal arteritis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:serum | RGD | PMID:8843867|REF_RGD_ID:8547826 |
MMP9 | Dog | temporal lobe epilepsy | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:cerebral cortex | RGD | PMID:22459050|REF_RGD_ID:8547829 |
MMP9 | Dog | thoracic aortic aneurysm | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:decreased activity:aorta (human) | RGD | PMID:16820601|REF_RGD_ID:1582351 |
MMP9 | Dog | thoracic aortic aneurysm | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA, protein:increased expression:aorta | RGD | PMID:20621845|REF_RGD_ID:5129489 |
MMP9 | Dog | thoracic aortic aneurysm | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16678588|REF_RGD_ID:1580554 |
MMP9 | Dog | thrombosis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with Arteriovenous Fistula;DNA:snp:promoter:g.-1562C>A (rs34016235) (human) | RGD | PMID:20616161|REF_RGD_ID:7207048 |
MMP9 | Dog | tongue squamous cell carcinoma | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:tongue (human) | RGD | PMID:26581505|REF_RGD_ID:11535375 |
MMP9 | Dog | transient cerebral ischemia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16197500|REF_RGD_ID:8547921 |
MMP9 | Dog | transient cerebral ischemia | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23046750|PMID:24773551|REF_RGD_ID:13207320|REF_RGD_ID:13207323 |
MMP9 | Dog | transient cerebral ischemia | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | protein:increased activity, increased expression:brain | RGD | PMID:11592852|REF_RGD_ID:8547930 |
MMP9 | Dog | tuberous sclerosis | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:cerebral cortex | RGD | PMID:22459050|REF_RGD_ID:8547829 |
MMP9 | Dog | tularemia | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:17202364|REF_RGD_ID:5130727 |
MMP9 | Dog | type 1 diabetes mellitus | | ISO | Mmp9 (Mus musculus) | 9068941 | protein:increased expression:kidney | RGD | PMID:23632630|REF_RGD_ID:13204760 |
MMP9 | Dog | type 2 diabetes mellitus | treatment | ISO | Mmp9 (Rattus norvegicus) | 9068941 | | RGD | PMID:23204894|REF_RGD_ID:8694120 |
MMP9 | Dog | type 2 diabetes mellitus | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma | RGD | PMID:18552985|REF_RGD_ID:8547849 |
MMP9 | Dog | type 2 diabetes mellitus | | ISO | MMP9 (Homo sapiens) | 9068941 | protein:increased expression:plasma (human) | RGD | PMID:17320450|REF_RGD_ID:7207195 |
MMP9 | Dog | urinary bladder cancer | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:17466450|REF_RGD_ID:2290395 |
MMP9 | Dog | varicose veins | | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:16465063|REF_RGD_ID:1582620 |
MMP9 | Dog | Venous Thrombosis | | ISO | Mmp9 (Mus musculus) | 9068941 | | RGD | PMID:16920980|REF_RGD_ID:1582648 |
MMP9 | Dog | Venous Thrombosis | | ISO | Mmp9 (Rattus norvegicus) | 9068941 | mRNA:increased expression:femoral vein (rat) | RGD | PMID:20515599|REF_RGD_ID:2325775 |
MMP9 | Dog | ventricular septal defect | severity | ISO | MMP9 (Homo sapiens) | 9068941 | | RGD | PMID:21238444|REF_RGD_ID:13204804 |
MMP9 | Dog | viral encephalitis | | ISO | MMP9 (Homo sapiens) | 9068941 | associated with influenza; protein:increased expression:serum | RGD | PMID:17529876|REF_RGD_ID:5130920 |